What question did this study set out to answer?

To evaluate the prognostic significance of red blood cell immunization in patients with myelodysplastic syndromes.

Red blood cell immunization as an independent predictor of survival in the myelodysplastic syndromes

View Full Paper

Ask AI

Bookmark

Authors

Analysis investigates RBC immunization's impact on survival in transfused MDS patients, suggesting significant implications.

To evaluate the prognostic significance of red blood cell immunization in patients with myelodysplastic syndromes.
Analyzed 486 transfused patients diagnosed with myelodysplastic syndromes.
Evaluated RBC immunization as a time-dependent covariate.
Applied competing risk methods to assess cumulative incidence of immunization.
69 patients (14.2%) developed RBC immunization, mainly anti-K and anti-E.
RBC immunization associated with a significant decrease in survival (hazard ratio: 11.9; p = 0.001).
Immunization did not predict progression to acute myeloid leukemia, but increased transfusion intensity was noted.

Pedraza et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark